Iqur Limited
Research and experimental development on biotechnology · London
ActiveUnited KingdomIncorporated 2003Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2026-03-31
IXBRL · 45 source facts · 18 selected values
Validation findingsXBRL valid
Accounts to 2026-03-31
IXBRL · 45 source facts · 18 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-04-01 to 2026-03-31
- Extraction status
- complete
- Numeric facts
- 26
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2606_04665665_20260331
- Source archive
- Accounts_Monthly_Data-June2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2025-03-31
IXBRL · 79 source facts · 22 selected values
Validation cleanXBRL valid
Accounts to 2025-03-31
IXBRL · 79 source facts · 22 selected values
Validation clean
XBRL valid
- Reporting period
- 2024-04-01 to 2025-03-31
- Extraction status
- complete
- Numeric facts
- 38
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- valid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2507_04665665_20250331
- Source archive
- Accounts_Monthly_Data-July2025.zip
Accounts to 2024-03-31
IXBRL · 80 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2024-03-31
IXBRL · 80 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2023-04-01 to 2024-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 41
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2266_04665665_20240331
- Source archive
- Accounts_Monthly_Data-June2024.zip
Accounts to 2023-03-31
IXBRL · 78 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 78 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 39
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0018_04665665_20230331
- Source archive
- Accounts_Monthly_Data-June2023.zip
Accounts to 2022-03-31
IXBRL · 71 source facts · 21 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 71 source facts · 21 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 32
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0002_04665665_20220331
- Source archive
- Accounts_Monthly_Data-December2022.zip
Accounts to 2021-03-31
IXBRL · 41 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 41 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 22
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0099_04665665_20210331
- Source archive
- Accounts_Monthly_Data-December2021.zip
Registered details
04665665- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2003-02-13
- Jurisdiction
- —
- Registered office
- THE LONDON BIOSCIENCE INNOVATION CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsThe Future Vaccine Manufacturing Research Hub (Vax-Hub)EPSRC · Research Grant · 2018-03-31 – 2023-08-31 · with 50 other participants£10,031,142whole project
The Future Vaccine Manufacturing Research Hub (Vax-Hub)
EPSRC · Research Grant · 2018-03-31 – 2023-08-31 · with 50 other participants
£10,031,142
whole project
University College LondonleadActivirosomes LtdApplikon Biotechnology B.V.AstrazenecaAstraZeneca (Global)BIA SeparationsBioLogicB, LLCButantan InstituteCell Therapy CatapultCentre for Process InnovationCentre for Process Innovation (CPI)DcvmnEnesi PharmaFujifilm UK LtdGE (General Electric Company)GlaxoSmithKline (Global)GlaxoSmithKline (GSK)HuvepharmaHvivoInDevRiQur LtdLondon School of Hygiene and Tropical Medicine (LSHTM)MerckMerck KGaAMicropore Technologies LtdMSD Wellcome Trust Hilleman LaboratoriesNational Institute for Biological Standards and Control (NIBSC)National Physical LaboratoryPall EuropePfizerPhenotypecaProBioMedProkarium LtdPT Bio FarmaPublic Health EnglandSanofi (International)SartoriusSerum Institute of IndiaSynthaceTeesside UniversityThe Biovac InstituteUK BioIndustry Association (BIA)Univercells LtdUniversity of Arkansas Medical CenterUniversity of KansasUniversity Of OxfordUniversity of SurreyVabiotechVaccitech LtdVinnovaVironova
Development of a novel VLP based vaccine for malariaLeadInnovate UK · Feasibility Studies · 2013-09-01 – 2014-08-31 · with 1 other participant£51,737awarded
Development of a novel VLP based vaccine for malariaLead
Innovate UK · Feasibility Studies · 2013-09-01 – 2014-08-31 · with 1 other participant
£51,737
awarded
University of Oxford£100,000
Iqur Limitedlead£51,737
Commercial manufacture of a novel dual hepatitis vaccine (Hepatacore)LeadInnovate UK · Collaborative R&D · 2009-11-01 – 2012-07-31 · with 2 other participants£350,357awarded
Commercial manufacture of a novel dual hepatitis vaccine (Hepatacore)Lead
Innovate UK · Collaborative R&D · 2009-11-01 – 2012-07-31 · with 2 other participants
£350,357
awarded
Commercial Development of Tandem-Core based vaccines for HepatitisLeadInnovate UK · Collaborative R&D · 2007-09-01 – 2009-11-30 · with 3 other participants£171,500awarded
Commercial Development of Tandem-Core based vaccines for HepatitisLead
Innovate UK · Collaborative R&D · 2007-09-01 – 2009-11-30 · with 3 other participants
£171,500
awarded